Gyre Therapeutics, Inc. (GYRE)
USD 7.24
(-4.99%)
USD 7.24
(-4.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 25.89 Million | -33.09 Million | -83.75 Million | -55.04 Million | -43.61 Million | -28.55 Million |
| Net Income | -85.48 Million | -8.24 Million | -87.93 Million | -56.24 Million | -55.17 Million | -30.05 Million |
| Depreciation & Amortization | 1.11 Million | 230 Thousand | 290 Thousand | 138 Thousand | 146 Thousand | 149 Thousand |
| Deferred income taxes | -1.16 Million | -838 Thousand | -3.88 Million | -1.05 Million | -11.41 Million | - |
| Stock-based compensation | 7.28 Million | 13.36 Million | -283.17 Thousand | 3.62 Million | 3.2 Million | 2.6 Million |
| Change in working capital | 7.45 Million | -4.94 Million | 483 Thousand | -2.57 Million | 8.21 Million | -1.36 Million |
| Other non-cash items | 96.67 Million | -21.48 Million | 3.88 Million | 1.05 Million | 11.41 Million | 116 Thousand |
| Investing Cash Flow | -19.76 Million | 55.42 Million | 48.18 Million | 9.66 Million | 27.39 Million | -71.32 Million |
| Investments in PPE | -8.58 Million | -4.99 Million | -839 Thousand | -267 Thousand | -64 Thousand | -376 Thousand |
| Acquisitions | 4.02 Million | 55.49 Million | - | -9.93 Million | -27.45 Million | - |
| Investment purchases | -15.73 Million | -50.51 Million | - | -97.63 Million | -129.97 Million | -198.91 Million |
| Sales/Maturities of investments | 595 Thousand | 57.5 Million | 49.02 Million | 107.56 Million | 157.43 Million | 127.96 Million |
| Other Investing Activities | -55 Thousand | -2.06 Million | 49.02 Million | 9.93 Million | 27.45 Million | -70.94 Million |
| Financing Cash Flow | 2.5 Million | -45.01 Million | 49.55 Million | 60.37 Million | 327 Thousand | 111.33 Million |
| Debt repayment | - | -3.21 Million | -6.7 Million | - | - | -5.08 Million |
| Dividends payments | - | -45.03 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.5 Million | 20 Thousand | 49.25 Million | 59.94 Million | 327 Thousand | 106.76 Million |
| Other Financing Activities | 2.5 Million | 20 Thousand | 303 Thousand | 435 Thousand | 327 Thousand | 9.65 Million |
| Accounts receivables | 1.39 Million | 1.61 Million | 1.49 Million | 11.68 Million | -15 Million | - |
| Accounts payables | 192 Thousand | -6.22 Million | 500 Thousand | 1.65 Million | 3.03 Million | 500 Thousand |
| Inventory | 1.74 Million | -879 Thousand | 3.88 Million | -3.04 Million | -490 Thousand | - |
| Other working capital | 4.12 Million | 541 Thousand | -5.39 Million | -12.86 Million | 20.67 Million | -1.86 Million |
| Cash at beginning of period | 25.17 Million | 44.34 Million | 30.36 Million | 15.36 Million | 31.26 Million | 19.8 Million |
| Cash at end of period | 33.5 Million | 21.66 Million | 44.34 Million | 30.36 Million | 15.36 Million | 31.26 Million |
| Capital Expenditure | -8.58 Million | -4.99 Million | -839 Thousand | -267 Thousand | -64 Thousand | -376 Thousand |
| Effect of forex changes on cash | -298 Thousand | -1.89 Million | - | - | - | - |
| Net cash flow / Change in cash | 8.33 Million | -22.68 Million | 13.98 Million | 14.99 Million | -15.89 Million | 11.45 Million |
| Free Cash Flow | 17.3 Million | -38.09 Million | -84.59 Million | -55.31 Million | -43.67 Million | -28.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.53 Million | 9.93 Million | -85.48 Million | -52.19 Million | -1.57 Million | -2.47 Million |
| Depreciation & Amortization | 238 Thousand | 425 Thousand | 1.11 Million | 48.67 Thousand | 63 Thousand | 1000.00 |
| Deferred income taxes | -97 Thousand | -313 Thousand | -1.16 Million | -3.18 Million | -1.2 Million | 56 Thousand |
| Stock-based compensation | 16 Thousand | 11 Thousand | 7.28 Million | 3.48 Million | 98 Thousand | 89 Thousand |
| Change in working capital | -7.38 Million | -2.75 Million | 7.45 Million | 4.32 Million | -1.73 Million | -89 Thousand |
| Other non-cash items | -2.8 Million | -4.41 Million | 96.67 Million | 48.35 Million | 1.14 Million | -56 Thousand |
| Investing Cash Flow | -8.27 Million | -7.22 Million | -19.76 Million | -776.14 Thousand | 1 Million | 4.79 Million |
| Investments in PPE | -1.45 Million | -231 Thousand | -8.58 Million | -2.37 Million | -2.42 Million | -1.84 Million |
| Acquisitions | 218 Thousand | 50 Thousand | 4.02 Million | 2.73 Million | 2.73 Million | 5 Million |
| Investment purchases | -7.03 Million | -7.03 Million | -15.73 Million | - | - | -3.15 Million |
| Sales/Maturities of investments | - | - | 595 Thousand | - | - | 5 Million |
| Other Investing Activities | 218 Thousand | 50 Thousand | -55 Thousand | -1.13 Million | 696.69 Thousand | -205 Thousand |
| Financing Cash Flow | 156 Thousand | 658 Thousand | 2.5 Million | 1.38 Million | -1.47 Million | -3.5 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | -1.5 Million | -3.5 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 275 Thousand | 658 Thousand | 2.5 Million | - | 22 Thousand | - |
| Other Financing Activities | 156 Thousand | 658 Thousand | 2.5 Million | 1.38 Million | 22 Thousand | -131.34 Thousand |
| Accounts receivables | -3.27 Million | 1000.00 | 1.39 Million | -869.84 Thousand | -1.2 Million | 1.53 Million |
| Accounts payables | -60 Thousand | -23 Thousand | 192 Thousand | - | 153 Thousand | -11 Thousand |
| Inventory | -719 Thousand | -666 Thousand | 1.74 Million | 565.42 Thousand | 574.11 Thousand | 301.07 Thousand |
| Other working capital | -3.32 Million | -2.06 Million | 4.12 Million | 4.63 Million | -1.26 Million | -1.91 Million |
| Cash at beginning of period | 29.78 Million | 33.5 Million | 25.17 Million | - | 6.92 Million | 8.09 Million |
| Cash at end of period | 16.09 Million | 29.78 Million | 33.5 Million | 4.48 Million | 2.22 Million | 6.92 Million |
| Capital Expenditure | -1.45 Million | -231 Thousand | -8.58 Million | -2.37 Million | -2.42 Million | -1.84 Million |
| Effect of forex changes on cash | -78 Thousand | -46 Thousand | -298 Thousand | -149 Thousand | 3.79 Million | - |
| Net cash flow / Change in cash | -13.68 Million | -3.72 Million | 8.33 Million | 4.48 Million | -4.69 Million | -1.17 Million |
| Free Cash Flow | -6.94 Million | 2.65 Million | 17.3 Million | 1.65 Million | -5.64 Million | -4.31 Million |
CBDHF
002329
IPHYF
BMRPF
MYOR
VQS